In a recent development, a cold and flu treatment sold by a major wholesale retailer has been taken off the shelves due to potential contamination. The issue pertains to a specific batch of over-the-counter medicine, raising concerns about product safety for consumers.
A widely used cold and flu medication has been recalled from select locations in the Midwest and Southeast due to potential contamination with foreign materials. The affected product is identified as a specific lot of Kirkland Signature Severe Cold & Flu Plus Congestion, according to a notice on the retailer’s website.
The product, with item number #1729556 and lot code P140082, was available to consumers between October 30 and November 30, 2024. The recall was initiated as a precautionary measure after an accidental shipment of a rejected batch was discovered by LNK International, the product’s manufacturer.
Customers in possession of the affected lot are advised not to use it and to return the product to the point of purchase for a full refund. For further concerns, the manufacturer, LNK International, has provided a contact number and email for inquiries.
This recall follows a previous withdrawal of over 8,000 boxes of the same medicine by the FDA. The prior recall was based on findings that the ingredient oral phenylephrine was ineffective as a nasal decongestant in its oral form, and could potentially cause adverse effects at higher doses.
In response to both recalls, concerned consumers are encouraged to verify their purchases and take the recommended actions to ensure their health and safety. While the recalls are cited as precautionary, they highlight the importance of vigilance in the production and distribution of over-the-counter medications.
The recall of this cold and flu treatment underscores the importance of rigorous quality control in the pharmaceutical industry. Consumers are urged to stay informed about the products they use and report any concerns to the manufacturers or relevant authorities.
Source: Fox13news
